Cargando…

Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy

Idiopathic pulmonary fibrosis (IPF) is a rare and severe disease with a median survival of ~3 years. Nintedanib (NTD) has been shown to be useful in controlling interstitial lung disease (ILD) in IPF. Here we describe the experience of NTD use in IPF in a real-life setting. Objective. Our objective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruaro, Barbara, Gandin, Ilaria, Pozzan, Riccardo, Tavano, Stefano, Bozzi, Chiara, Hughes, Michael, Kodric, Metka, Cifaldi, Rossella, Lerda, Selene, Confalonieri, Marco, Baratella, Elisa, Confalonieri, Paola, Salton, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959830/ https://www.ncbi.nlm.nih.gov/pubmed/37259452 http://dx.doi.org/10.3390/ph16020307

Ejemplares similares

Pulmonary Sarcoidosis and Immune Dysregulation: A Pilot Study on Possible Correlation
por: Cifaldi, Rossella, et al.
Publicado: (2023)

Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat?
por: Ruaro, Barbara, et al.
Publicado: (2022)

Chronic Thromboembolic Pulmonary Hypertension: An Observational Study
por: Ruaro, Barbara, et al.
Publicado: (2022)

Severe COVID-19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail?
por: Ruaro, Barbara, et al.
Publicado: (2022)

Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS
por: Salton, Francesco, et al.
Publicado: (2022)

Host-Based Treatments for Severe COVID-19
por: Mondini, Lucrezia, et al.
Publicado: (2023)

Biomarkers in Systemic Sclerosis: An Overview
por: Di Maggio, Giuseppe, et al.
Publicado: (2023)

Microvascular Alteration in COVID-19 Documented by Nailfold Capillaroscopy
por: Mondini, Lucrezia, et al.
Publicado: (2023)

The Relationship between Pulmonary Damage and Peripheral Vascular Manifestations in Systemic Sclerosis Patients
por: Ruaro, Barbara, et al.
Publicado: (2021)

Correlation between Microvascular Damage and Internal Organ Involvement in Scleroderma: Focus on Lung Damage and Endothelial Dysfunction
por: D’Oria, Mario, et al.
Publicado: (2022)

Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter—A Critical Review and Viewpoints
por: Salton, Francesco, et al.
Publicado: (2023)

Correlation between Potential Risk Factors and Pulmonary Embolism in Sarcoidosis Patients Timely Treated
por: Ruaro, Barbara, et al.
Publicado: (2021)

Clinical Evaluation of the ButterfLife Device for Simultaneous Multiparameter Telemonitoring in Hospital and Home Settings
por: Salton, Francesco, et al.
Publicado: (2022)

Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPAF Classification Criteria
por: Bozzao, Francesco, et al.
Publicado: (2023)

Epithelial–Mesenchymal Transition: A Major Pathogenic Driver in Idiopathic Pulmonary Fibrosis?
por: Salton, Francesco, et al.
Publicado: (2020)

Editorial: Obstructive sleep apnea syndrome (OSAS). What's new?
por: Ruaro, Barbara, et al.
Publicado: (2022)

An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients
por: Ruaro, Barbara, et al.
Publicado: (2022)

Interstitial lung disease in patients with antisynthetase syndrome: a retrospective case series study
por: Baratella, Elisa, et al.
Publicado: (2020)

Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease
por: Mitja, Jevnikar, et al.
Publicado: (2015)

High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients
por: Ruaro, Barbara, et al.
Publicado: (2021)

High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose?
por: Ruaro, Barbara, et al.
Publicado: (2021)

Editorial: Pulmonary fibrosis: One manifestation, various diseases
por: Ruaro, Barbara, et al.
Publicado: (2022)

Evaluation of Correlations between Genetic Variants and High-Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis
por: Baratella, Elisa, et al.
Publicado: (2021)

Chronic Thromboembolic Pulmonary Hypertension: An Update
por: Ruaro, Barbara, et al.
Publicado: (2022)

What Role Does Trabecular Bone Score Play in Chronic Inflammatory Rheumatic Diseases?
por: Ruaro, Barbara, et al.
Publicado: (2020)

The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung
por: Ruaro, Barbara, et al.
Publicado: (2021)

Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF)
por: Confalonieri, Paola, et al.
Publicado: (2022)

The Treatment of Lung Involvement in Systemic Sclerosis
por: Ruaro, Barbara, et al.
Publicado: (2021)

Laser Speckle Contrast Analysis: Functional Evaluation of Microvascular Damage in Connective Tissue Diseases. Is There Evidence of Correlations With Organ Involvement, Such as Pulmonary Damage?
por: Ruaro, Barbara, et al.
Publicado: (2021)

Chronic Obstructive Pulmonary Disease Definition: Is It Time to Incorporate the Concept of Failure of Lung Regeneration?
por: Confalonieri, Marco, et al.
Publicado: (2022)

Higher, but Not Too High, Dose Is Only One Determinant of Corticosteroid Treatment Success in Severe COVID-19
por: Salton, Francesco, et al.
Publicado: (2023)

Different Methods to Improve the Monitoring of Noninvasive Respiratory Support of Patients with Severe Pneumonia/ARDS Due to COVID-19: An Update
por: Pelosi, Paolo, et al.
Publicado: (2022)

The Updated Role of Ultrasound in Assessing Dermatological Manifestations in Systemic Sclerosis
por: Ruaro, Barbara, et al.
Publicado: (2021)

Interstitial Lung Disease at High Resolution CT after SARS-CoV-2-Related Acute Respiratory Distress Syndrome According to Pulmonary Segmental Anatomy
por: Baratella, Elisa, et al.
Publicado: (2021)

Epithelial–Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis
por: Salton, Francesco, et al.
Publicado: (2019)

Nintedanib Treatment for Idiopathic Pulmonary Fibrosis Patients Who Have Been Switched from Pirfenidone Therapy: A Retrospective Case Series Study
por: Vianello, Andrea, et al.
Publicado: (2020)

Editorial: Evolution in respiratory pharmacology
por: Ruaro, Barbara, et al.
Publicado: (2023)

Radiological–pathological signatures of patients with COVID-19-related pneumomediastinum: is there a role for the Sonic hedgehog and Wnt5a pathways?
por: Baratella, Elisa, et al.
Publicado: (2021)

Low arousal threshold: a common pathophysiological trait in patients with obstructive sleep apnea syndrome and asthma
por: Antonaglia, Caterina, et al.
Publicado: (2022)

Editorial: Osteoporosis in Rheumatic Diseases, What's New?
por: Ruaro, Barbara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5d305slg7lpq11uhflu3l7pkp3